Schedule At a Glance

  • MAY 25
  • MAY 26
  • MAY 27
  • MAY 28

 

Click any time to find out what time it will be locally

Click any time to find out what time it will be for you

A half-day educational event providing unparalleled access to cell and gene therapy key opinion leaders.

Access is reserved for investors and analysts interested in learning about the latest advancements in cell and gene therapy translation and in meeting leading experts from across the commercialization pipeline.

Learn more and RSVP here

Sessions will feature small group networking for an informal, interactive opportunity to meet with other ESPs from around the world that share an interest in cell and gene therapy.

Learn More

Hosted by the ISCT Europe Regional Executive Committee

Connect with your peers, ISCT colleagues, and other like-minded professionals leading the translation of cell and gene therapies. Your participation will help your regional leadership identify and provide the support needed to promote the development of safe and effective cell and gene therapies in your region.

Learn More

Browse posters, watch elevator-pitches and videos, and connect directly with poster presenters through text and video to discuss their novel research.

While posters will remain accessible during the entire conference, poster presenters will be available to chat live during the dedicated hours to answer your questions.

Learn More

Browse exhibits, watch engaging state of the art presentations, and connect directly with exhibitors through text and video chat functions to further discuss their research and products.

While exhibit booths will remain accessible during the entire conference, exhibitors will be available to chat live during the dedicated hours to answer your questions.

Learn More

An opportunity to recapitulate the breadth and depth of ISCT activities in the past year and to communicate developments in the organization. As part of the ISCT AGM, selected highlights from the 2020 Annual Report will be discussed, elections results will be announced, and the membership and financial reports will be disclosed.

Learn More

Hosted by the ISCT North America Regional Executive Committee

Connect with your peers, ISCT colleagues, and other like-minded professionals leading the translation of cell and gene therapies. Your participation will help your regional leadership identify and provide the support needed to promote the development of safe and effective cell and gene therapies in your region.

Learn More

Hosted by the ISCT South & Central America Regional Executive Committee

Connect with your peers, ISCT colleagues, and other like-minded professionals leading the translation of cell and gene therapies. Your participation will help your regional leadership identify and provide the support needed to promote the development of safe and effective cell and gene therapies in your region.

Learn More

Sessions will feature small group networking for an informal, interactive opportunity to meet with other ESPs from around the world that share an interest in cell and gene therapy.

Learn More

Hosted by the ISCT Australia & New Zealand Regional Executive Committee

Connect with your peers, ISCT colleagues, and other like-minded professionals leading the translation of cell and gene therapies. Your participation will help your regional leadership identify and provide the support needed to promote the development of safe and effective cell and gene therapies in your region.

Learn More

Browse posters, watch elevator-pitches and videos, and connect directly with poster presenters through text and video to discuss their novel research.

While posters will remain accessible during the entire conference, poster presenters will be available to chat live during the dedicated hours to answer your questions.

Learn More

Browse exhibits, watch engaging state of the art presentations, and connect directly with exhibitors through text and video chat functions to further discuss their research and products.

While exhibit booths will remain accessible during the entire conference, exhibitors will be available to chat live during the dedicated hours to answer your questions.

Learn More

Hosted by the ISCT Asia Regional Executive Committee

Connect with your peers, ISCT colleagues, and other like-minded professionals leading the translation of cell and gene therapies. Your participation will help your regional leadership identify and provide the support needed to promote the development of safe and effective cell and gene therapies in your region.

Learn More

 

 

Click any time to find out what time it will be locally

Click any time to find out what time it will be locally

  • ISCT 2021 Welcome Address from President & Organizing Committee

In 2020, MSC therapies offered ‘a new hope’ for treating COVID-19. At the ISCT 2020 Virtual Meeting, ISCT explored the scientific rationale and growing list of MSC trials for COVID-19 induced acute respiratory distress syndrome (ARDS). One year later, our panelists return to provide an update on the very latest results from ongoing MSC trials for COVID-19, and to discuss how we can apply this new knowledge to address the ongoing hurdles to MSC therapeutic development.

Chair:
Jacques Galipeau, MD

Speakers: 
Maroun Khoury, PhD
Patricia Rocco, MD, PhD
Anthony Ting, PhD

Click to find Out More

  • Fireside Chat: Plenary Debrief – what did we learn? 

MSC Session I 

Chair
Don Phinney, PhD (US)

Speakers:
Bas von Balkom, PhD (NL)
Claudia dos Santos, MD (CA)
Sai-Kiang Lim, PhD (SG)

COMmercialization Session I 

Session Chair
Dominic Clarke, PhD (US)

Speakers:
David Sourdive, PhD (FR)
James Trager, PhD (US)
Christopher Bravery, PhD (UK)

MSC Session Ii

Chair:
Karin Tarte, PharmD, PhD (FR)

Speakers:
Frank Barry, PhD (IE)
Deborah Kehl (CH)
Ivan Martin, PhD (CH)
Kristina Thamm, PhD (DE)

commercialization Session Ii

JOINT SESSION WITH WHO

Chair:
Raffaella Balocco Mattavelli, PharmD, PhD (CH)
Massimo Dominici, MD (IT)

Speakers:
Ursula Lolzides, PhD (CH)
Anthony Ting, PhD (US)
Peter Marks, MD, PhD (US)
Marcos Timón, PhD (ES)
Tony Manderson, PhD (AU)

Regulatory Session i

Chair:
Forthcoming

Speakers: 
Pia Mountford, PhD (US)
Gary Rea (US)
Eduard Luss (US)
Luis Barrera, PhD (US)

HOT TOPICS
INDUSTRY ROUNDTABLE I
Starting 12:30 EDT

Join us for the presentation of the 2021 ISCT Career Achievement Award, the Inaugural Darwin J. Prockop Mentoring Award, and the Inaugural Le Prix Luc Sensebé Innovation Award

“Forecasts demonstrate that approvals-wise, we are looking at 10-20 items being considered per year by 2025. For some time now, we have been lining up to build the research and the knowledge needed for cell and gene therapies to flourish… The questions we can ask now pivot towards how approval should be approached, how reimbursement might look, how patients can get access to therapies, and so on.” 

Co-Chair: 
Bruce Levine, PhD
Shabnum Patel, PhD

Speakers:
Peter Marks, MD, PhD
Arie Belldegrun, MD
Matthew Porteus, MD, PhD 

  • Fireside Chat – Presidential Plenary Debrief with ESP Co-Chair Shabnum Patel 

Expert Q&A

Industry thought leader, John Conway will lead this discussion on Digital Transformation in biologics manufacturing and quality control operations. Life science companies are increasingly looking to technology-based innovation to drive R&D pipelines, digital capabilities, novel therapies, and new commercial engagement models. L7 Informatics Chief Operating Officer, Trent Carrier, Ph.D., MBA, and a leading CDMO will join this discussion providing a 360-degree discussion.

MSC Session III

Chair:
Sowmya Viswanathan, PhD (CA)

Speakers:
Mauro Krampera, MD (IT)
Eleuterio Lombardo, PhD (ES)

COMmercialization Session III

Co-Chairs:

Julie Allickson, PhD (US)
Patrick Rivers, MBA (US)

Speakers:
Reni Benjamin, PhD (US)
Matthew Durdy (UK)
Stephanie Farnia, MPH (US)

SCALEREADY SYMPOSIUM

MSC Session IV

Co-Chairs:
Christian Jorgensen, MD, PhD (IT)
George Muschler MD (US)

Speakers:
Oscar Lee MD, PhD (TW)
Norimasa Nakamura, MD, PhD (JP)
Felipe Prosper, MD, PhD (ES)

COMmercialization Session IV

Chair:
John McMannis (US)

Speakers:
Jason Foster, MBA (UK)
Fabian Gerlinghaus (US)
Martin Giedlin (US)
Megan Suhoski Davis, PhD (US)

Regulatory session II

Chair:
Laertis Ikonomou, PhD (US)

Speakers: 
Patricia Zettler, JD (US)
Virginia Lyons (US)

  • Fireside Chat – Presidential Plenary Debrief with ESP Co-Chair Shabnum Patel 

Click any time to find out what time it will be for you

Click any time to find out what time it will be locally

Human trials of exosome therapeutics mark the arrival of true clinical translation. Understanding manufacturing and regulatory challenges is critical to ensure a smooth translational path forward. The panel considers the translation of current preclinical data and lessons learned from research to date to examine where consensus is needed, and how it can be developed.

Co-Chairs:
Sai-Kiang Lim, PhD (SG)
Maurizio Muraca, MD, PHD (IT)

Speakers: 
Massimo Dominici, MD (IT)
Eva Rohde, MD (DE)
Andrew Hoffman, DVM, DVSc (US)

Click here to learn more

Exosomes/Novel Technologies Session I 

Chair:
Bernd Giebel, PhD (DE)

Speakers:
Chulhee Choi, MD, PhD (KR)
Samir El Andaloussi, PhD (SE)
Le Thi Nguyet Minh, PhD (SG)

Stem Cell engineering session i

Co-Chairs:
Duncan Purtill, MD (AU)
Robert Wynn, MD, MB BChir, MRCP FRCPath (UK)

Speakers:
Juliet Barker, MBBS (US)
Charles Craddock, CBE, FRCP, FRCPath, DPhil (UK)
David Curtis, MBBS, PhD, FRACP, FRCPA (AU)
Kanya Rajangam, MBBS, PhD (US)

CYTIVA SYMPOSIUM

EXOSomes/novel technologies session ii

Co-Chairs:
Dominique de Kleijn, PhD (NL)
Andrew Hoffman, DVM, DVSc (US)

Speakers:
Saumya Das, MD, PhD (US)
Eduardo Marban, MD, PhD (US)
Vicky Yang, DVM, PhD, DACVIM (cardiology) (US)

STEM CELL ENGINEERING SESSION II

Co-Chairs:
Alice Bertaina, MD, PhD (US)
Carmem Bonfim, MD, PhD (BR)

Speakers:
Amy DeZern, MD, MHS (US)
Orly Klein, MD (US)
Arina Lazareva (UK)
Parinda Mehta, MD (US)

miltenyi biotec symposium

Hot Topics
Industry Roundtable II Starting 12:30 EDT

The panel aims to cover clinical updates exploring the latest data in gene therapy and alternative donor BMT for treating hemoglobinopathies, followed by a moderated debate with leading experts to understand accessibility, cost, endpoints, and outcomes of the currently available therapies for thalassemia and sickle cell disease. 

Co-Chairs:
Jaap Jan Boelens, MD, PhD
Sandeep Soni, MD

Speakers: 
Alexis Thompson, MD, MPH
Suradej Hongeng, MD

Debaters:
Selim Corbacioglu, MD
Matthew Porteus, MD, PhD
Deepa Manwani, MD

Click here to learn more

Focus Session
Labeling Standards

Co-Chairs:
Lizette Caballero, BSc, MLS(ASCP)CM (US)
Paul Ashford, MSc (UK)

Speakers:
Martin Hildebrandt, MD (DE)
Julie Allickson, PhD (US)
Dawn Henke, PhD (US)

Stem Cell engineering session III

JOINT SESSION WITH WMDA

Co-Chairs: 
Allistair Abraham, MD (US)
Annalisa Ruggeri, MD, PhD (IT)

Speakers:
Catherine Bollard, MD, MBchB (US)
Sandra Cohen, MD (CA)
May Daher, MD (US)
Mitchell Horwitz, MD (US)
Sergio Querol, MD, PhD (ES)
Andromachi Scaradavou, MD (US)

THERMO FISHER SYMPOSIUM

Chair:
Xavier De Mollerat Du Jeu, PhD (US)

Speakers:
Sean Chang, PhD (US)
Evan Zynda, PhD (US)
David Shaw, PhD (US)
Ben Schilling, PhD (US)

Exosomes/Novel Technologies Session IV

JOINT SESSION WITH ISEV

Co-Chairs:
Sai-Kiang Lim, PhD (SG)
Daniel Weiss, MD, PhD (US)

Speakers:
Lorena Martin-Jaular, PhD (FR)
Yong Song Gho, PhD (KR)
Kenneth Witwer, PhD (US)

Abstract Presenter:
Michael Bellio, PhD (US)

Stem Cell engineering session IV

Chair & Speaker
Susan Prockop, MD (US)

Speakers:
Kenneth Weinberg, MD (US)
Marcel van den Brink, MD, PhD (US)
Jurgen Kuball (NL)
Tamara Laskowski, PhD (US)

PENN MEDICINE SYMPOSIUM

Click any time to find out what time it will be locally

Click any time to find out what time it will be locally

Successfully translating tissue engineered and regenerative medicine products requires orchestration of numerous disciplines to realize the potential to repair, replace, and regenerate organs and tissues. This panel examines the state of the art, and key lessons from, stem cell therapy and 3d printing research, proposing a path forwards towards safe translation.

Co-Chairs:
Ranieri Cancedda, MD (IT)
Giuseppe Orlando, MD, PhD (US)

Speakers:
Anthony Atala, MD (US)
Graziella Pellegrini, PhD (IT)
Rocky Tuan, PhD (HK)

Click here to find out more

Tissue Engineering and regenerative medicine session i

Chair
Massimiliano Gnecchi, MD, PhD (IT)

Speakers:
Jozef Bartunek, MD, PhD (BE)
Stephan Janssens, MD, PhD (NL)
Giulio Pompilio, MD, PhD, FESC (IT)

immuno & Gene therapy session i

Co-Chairs:
Jaap Jan Boelens, MD, PhD (US)
Michael Scordo, MD (US)

Speakers:
David Teachey, MD (US)
Cameron Turtle, MBBS, PhD (US)

terumo symposium

Tissue Engineering and regenerative medicine session iI

Chair:
George Muschler, MD (US)

Speakers:
William J Maloney, MD (US)
Farshid Guilak, PhD (US)
Nicolas Piuzzi, MD (US)

Abstract Presenters:
Jesil Kasamkattil, MSc (CH)
Judith Krieger, MSc (DE)

immuno & Gene therapy session iI

Co-Chair: 
Sandeep Soni, MD (US)

Co-Chair & Speaker
Nicole Paulk, PhD (US)

Speakers:
Krystof Bankiewicz, MD, PhD (US)
Lindsey A. George, MD (US)

roche SYMPOSIUM

Hot Topic
Industry Roundtable
Starting 12:30 EDT

Description and Speakers Forthcoming

Leading experts in the field outline the benefits and challenges of autologous versus allogeneic sources of immune effector cells, drawing on their experiences in driving novel technologies within each setting. The panel will discuss how progress is contingent on addressing issues related to manufacturing, efficacy, regulatory approvals, cost, patient access, pricing, and
availability of therapies to underserved populations. Through this discussion, the panel aims to build consensus that supports decisions for the optimal uses of cellular immunotherapy sources.

Chair:
Michael Gustafson, PhD (US)

Speakers:
Rayne Rouce, MD (US)
Richard Anderson, PhD (US)

Click here to learn more

Hot Topic Industry Roundtable
Starting 15:00 EDT

Description and Speakers Forthcoming

Tissue Engineering and regenerative medicine session iII

Chair & Speaker:
Budd Tucker, PhD (US)

Speakers:
Molly Shoichet, FRS (CA)
Clive Svendsen (US)

immuno & Gene therapy session III

Co-Chairs: 
Patrick Hanley, PhD (US)
Margaret Lamb, MD (US)

Speakers:
Maksim Mamonkin, PhD (US)
Jason Dubovsky, PhD (US)
Lawrence Lamb, PhD (US)

REGULATORY SESSION III

Co-Chairs:
Karen Nichols, Esq. (US)
Karen Major (CA)

Speakers:
Aisha Khan, MSc, MBA (US)
Patrick Au, PhD (US)
Fouad Atouf, PhD (US)

Tissue Engineering and regenerative medicine session IV

Co-Chairs:
Rachele Ciccocioppo, MD (IT)
Vincenzo Cardinale, MD, PhD (IT)

Speakers:
Paolo De Coppi (UK)
Ekaterine Berishvili, MD, PhD (CH)
Geraldine Mitchell, MBChB (AU)

immuno & Gene therapy session IV

Co-Chairs:
Robert Mays, MD (US)
Charles S. Cox, MD (US)

Speakers:
Sangeeta S. Chavan, PhD (US)
Richard Maziarz (US)
Sean Savitz (US)

REGULATORY SESSION IV

Co-Chairs:
Karen Nichols, Esq. (US)
Dominic Wall, PhD, FFSc (RCPA) (AU)

Speakers:
Scott Burger, PhD (US)
Richard Snyder, MD (US)